Listed by the USPTO as LEE, HOI YAN NMN
Tech Center 1600 • Art Units: 1623 1693
This examiner grants 38% of resolved cases
LEE, HOI YAN NMN handles cases in Tech Center 1600 and Art Unit 1623. The profile covers 91 resolved cases, with an allowance rate of 38.5% and a median of 1273 days to allowance. Interview lift is 74.9%, the most prominent feature of this record, and it supports treating examiner interviews as a central prosecution tool.
The leading companies are President and Fellows of Harvard College, The Brigham and Women's Hospital Inc., and CJ CheilJedang Corporation. Ipsilon USA - NLO, Leason Ellis LLP, and OBLON, MCCLELLAND, MAIER & NEUSTADT, L.L.P. are the listed firms. Applicants may benefit from combining detailed written responses with well-prepared interviews.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17925180 | OLEOGEL AND OLEOPASTE COMPOSITIONS AND USES THEREOF | Non-Final OA | The Brigham and Women's Hospital, Inc. |
| 17297586 | D-PSICOSE CRYSTAL AND PREPARATION METHOD THEREFOR | Non-Final OA | CJ CHEILJEDANG CORPORATION |
| 18716928 | FUNCTIONALIZED CYCLODEXTRIN MONOMER AND POLYMER FOR WATER REMEDIATION | Non-Final OA | Cornell University |
| 17621987 | LIQUID PHASE SEPARATION OF 2G SUGARS BY ADSORPTION ON A FAU ZEOLITE HAVING A SI/AL ATOMIC RATIO GREATER THAN 1.5 | Final Rejection | IFP Energies nouvelles |
| 18788461 | COMPOSITIONS AND METHODS FOR CANCER AND TUMOR TREATMENT | Non-Final OA | Washington University |
| 18045744 | COMPOSITIONS AND METHODS FOR PREDICTING THERAPEUTIC OUTCOME | Non-Final OA | Washington University |
| 18695914 | DERIVATIVES FROM 2,5,6-TRIMETHYLCYCLOHEX-2-EN-1-OL AS AROMA INGREDIENTS | Non-Final OA | BASF SE |
| 17927616 | METHOD OF PRODUCING ALIPHATIC GLYCOSIDE COMPOUND OR SUGAR FATTY ACID ESTER COMPOUND | Final Rejection | TOHOKU UNIVERSITY |
| 18334457 | LIQUID COMPOSITION | Final Rejection | Shin-Etsu Chemical Co., Ltd. |
| 17606441 | STABILIZATION AND PRESERVATION OF IN VITRO TRANSCRIPTION REACTIONS | Final Rejection | President and Fellows of Harvard College |
| 17283728 | ENZYMATIC RNA SYNTHESIS | Non-Final OA | President and Fellows of Harvard College |
| 17995264 | PREPARATION FOR USE AS VASORELAXANT | Non-Final OA | Evonik Operations GmbH |
| 19262831 | AMORPHOUS FORM OF REDUCED ß-NICOTINAMIDE MONONUCLEOTIDE CALCIUM SALT, AND PREPARATION METHOD AND USE THEREFOR | Non-Final OA | EffePharm (Shanghai) Co., Ltd. |
| 18237624 | NASAL SPRAY USING PENTOSAN POLYSULFATE AND MUCOPOLYSACCHARIDE POLYSULFATE FOR COVID-19 PREVENTION AND TREATMENT | Final Rejection | Rensselaer Polytechnic Institute |
| 17998437 | INORGANIC POROUS SUBSTRATE, INORGANIC POROUS SUPPORT, AND NUCLEIC ACID PRODUCTION METHOD | Non-Final OA | SUMITOMO CHEMICAL COMPANY, LIMITED |
| 18714811 | SUBSTRATES FOR IMAGING GLUCOCEREBROSIDASE ACTIVITY | Non-Final OA | SIMON FRASER UNIVERSITY |
| 18568162 | COMPOSITIONS FOR TREATMENT OF PSORIASIS | Final Rejection | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS |
| 18577948 | MULTIPLEXING TARGETING LIGANDS THROUGH CLICK CHEMISTRY AT THE ANOMERIC SITE OF SUGARS | Non-Final OA | ALNYLAM PHARMACEUTICALS, INC. |
| 18724813 | MODIFIED POLYSACCHARIDE POLYMERS AND RELATED COMPOSITIONS AND METHODS THEREOF | Non-Final OA | SIGILON THERAPEUTICS, INC. |
| 18048407 | CAPPING COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | Final Rejection | Gritstone bio, Inc. |
| 17298283 | USE OF GUAR DERIVATIVES FOR MICROORGANISMS GROWTH | Non-Final OA | RHODIA OPERATIONS |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy38.5% of resolved applications examined by Hoi Yan Nmn Lee were allowed (91 resolved cases), compared with 51.0% across Art Unit 1623 over the last five years.
This examiner's interview lift is +74.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Hoi Yan Nmn Lee took 1,273 days on average from filing to allowance.
Hoi Yan Nmn Lee examines applications in Art Unit 1623 in Tech Center 1600 (Biotechnology & Pharmaceuticals).